Stock HBIO HARVARD BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Harvard Bioscience, Inc.

Equities

HBIO

US4169061052

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-16 pm EDT 		5-day change 1st Jan Change
4.18 USD -5.86% Intraday chart for Harvard Bioscience, Inc. -9.72% -21.87%
Apr. 09 Harvard Bioscience Reducing Headcount MT
Apr. 09 Harvard Bioscience, Inc. Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Harvard Bioscience Reducing Headcount
MT
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
GL
Harvard Bioscience, Inc. Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
CI
Harvard Bioscience, Inc. Enters into A Third Amendment to the Credit Agreement
CI
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
GL
Transcript : Harvard Bioscience, Inc., Q4 2023 Earnings Call, Mar 07, 2024
Harvard Bioscience: Q4 Earnings Snapshot
AQ
Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q4 Revenue $28.2M
MT
Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q4 EPS $0.04
MT
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
GL
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
AQ
Harvard Bioscience, Inc. Provides Revenue Guidance for the Full Year 2024
CI
Harvard Bioscience, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
North American Morning Briefing : Powell Still in -2-
DJ
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
GL
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications At Society of Toxicology Meeting
CI
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
GL
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
AQ
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
GL
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HBIO Stock
  4. News Harvard Bioscience, Inc.